Profile data is unavailable for this security.
About the company
Oxford BioMedica Plc is a United Kingdom-based gene and cell therapy company. The Company and its subsidiaries have developed lentiviral vector delivery system, LentiVector platform, which the Company leverages to develop in vivo and ex vivo products both in-house and with partners. Its LentiVector delivery platform has created a portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology, central nervous system (CNS) disorders and liver diseases. The Company's product pipeline includes OXB-302, OXB-203, OXB-204 and OXB-103 and OXB-401. The Company has also developed partnership with various pharmaceutical companies to develop potential gene and cell therapy products. Its partnered products include AXO-LENTI-PD, SAR 422459 and SAR421869.
- Revenue in GBP (TTM)87.73m
- Net income in GBP-6.25m
- Incorporated1996
- Employees673.00
- LocationOxford BioMedica PLCWindrush Court, Transport WayOXFORD OX4 6LTUnited KingdomGBR
- Phone+44 186 578 3000
- Fax+44 186 578 3001
- Websitehttp://www.oxfordbiomedica.co.uk
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arix Bioscience PLC | 477.00k | 126.30m | 231.20m | 330.00 | 1.99 | 0.7293 | -- | 484.69 | 0.8882 | 0.8882 | 0.0034 | 2.42 | 0.0018 | -- | 0.3841 | 1,445.46 | 46.78 | -- | 47.52 | -- | -- | -- | 26,478.20 | -- | -- | -- | 0.0008 | -- | -5.73 | -- | 281.25 | -- | -- | -- |
| Eco Animal Health Group Plc | 85.90m | 3.68m | 237.00m | 204.00 | 68.04 | 2.87 | 27.05 | 2.76 | 0.0514 | 0.0514 | 1.20 | 1.22 | 0.8012 | 2.17 | 3.52 | 421,053.90 | 6.42 | 8.48 | 8.33 | 10.27 | 48.25 | 47.20 | 8.02 | 13.76 | 2.27 | 5.48 | 0.0596 | 62.00 | 7.22 | 13.08 | -64.40 | -8.81 | -13.81 | -- |
| Sareum Holdings Plc | 47.20k | -926.91k | 248.16m | 6.00 | -- | 177.80 | -- | 5,257.73 | -0.0003 | -0.0003 | 0.00001 | 0.0004 | 0.0316 | -- | 0.7098 | 7,866.67 | -62.02 | -48.02 | -71.74 | -51.95 | -- | -- | -1,963.79 | -9,651.86 | -- | -24.86 | 0.00 | -- | -- | -- | 32.12 | -- | -- | -- |
| Creo Medical Group PLC | 9.43m | -20.32m | 299.35m | 217.00 | -- | 4.68 | -- | 31.75 | -0.1303 | -0.1303 | 0.0605 | 0.3978 | 0.1038 | 1.43 | 2.60 | 43,451.06 | -22.35 | -- | -26.24 | -- | 42.79 | -- | -215.46 | -- | 2.46 | -- | 0.1644 | -- | 69,899.11 | -- | -27.68 | -- | -- | -- |
| Amryt Pharma Holdings Ltd | 135.48m | -66.97m | 300.47m | 99.00 | -- | 7.61 | -- | 2.22 | -0.4051 | -0.4051 | 0.8227 | 0.2202 | -- | -- | -- | -- | -- | -22.53 | -- | -27.22 | 41.06 | 37.63 | -49.43 | -86.26 | 1.73 | -1.81 | 0.7831 | -- | 214.17 | -- | -65.92 | -- | -- | -- |
| Synairgen plc | 0.00 | -13.92m | 307.87m | 18.00 | -- | 3.62 | -- | -- | -0.0986 | -0.0986 | 0.00 | 0.4259 | 0.00 | -- | -- | 0.00 | -30.05 | -30.56 | -31.80 | -33.63 | -- | -- | -- | -431.93 | 25.86 | -- | 0.0015 | -- | -- | -- | -258.20 | -- | 50.02 | -- |
| Avacta Group Plc | 3.64m | -18.89m | 355.11m | 123.00 | -- | 5.71 | -- | 97.67 | -0.0901 | -0.0901 | 0.0176 | 0.2451 | 0.0759 | 7.20 | 1.46 | 29,560.98 | -39.41 | -- | -41.92 | -- | 59.98 | -- | -519.55 | -- | 14.02 | -72.42 | 0.0319 | -- | -- | -- | -- | -- | -- | -- |
| Alliance Pharma plc | 129.80m | 8.03m | 535.31m | 221.00 | 68.21 | 1.90 | 31.61 | 4.12 | 0.0147 | 0.0147 | 0.2416 | 0.5272 | 0.2833 | 2.44 | 5.15 | 587,334.80 | 1.75 | 5.27 | 1.86 | 6.11 | 63.80 | 61.01 | 6.18 | 16.87 | 1.80 | 8.99 | 0.3358 | 31.58 | -4.30 | 21.84 | -67.90 | -8.76 | -49.06 | 7.92 |
| Ergomed PLC | 86.39m | 9.68m | 563.86m | 1.01k | 60.36 | 10.68 | 38.82 | 6.53 | 0.1913 | 0.1913 | 1.71 | 1.08 | 1.16 | -- | 4.40 | 85,620.41 | 12.96 | 0.6093 | 19.38 | 0.8377 | 45.90 | 39.93 | 11.21 | 0.5741 | -- | 15.88 | 0.0881 | 0.00 | 26.57 | 23.41 | 73.86 | 44.22 | 11.91 | -- |
| Vectura Group PLC | 190.60m | 122.40m | 903.92m | 500.00 | 7.49 | 1.65 | 5.26 | 4.74 | 0.2016 | 0.2016 | 0.3339 | 0.9135 | 0.3185 | 3.16 | 1.57 | 381,200.00 | 20.46 | -- | 23.37 | -- | 53.20 | -- | 64.22 | -- | 3.25 | 5.27 | 0.0077 | -- | 6.90 | -- | 653.85 | -- | -- | -- |
| Puretech Health PLC | 8.55m | 4.35m | 987.10m | 66.00 | 523.90 | 2.02 | 121.18 | 115.44 | 0.0066 | 0.0066 | 0.0295 | 1.70 | 0.0122 | -- | 5.19 | 129,553.20 | 0.4731 | 5.35 | 0.5554 | 7.07 | -- | -- | 38.82 | 290.68 | -- | -- | 0.1049 | 0.00 | 20.00 | -0.1017 | -98.58 | -- | 3.31 | -- |
| Oxford BioMedica plc | 87.73m | -6.25m | 1.10bn | 673.00 | -- | 9.73 | 306.10 | 12.54 | -0.0817 | -0.0817 | 1.10 | 1.37 | 0.5718 | 8.78 | 2.51 | 130,353.60 | -4.07 | -8.50 | -5.54 | -11.41 | 52.52 | 54.07 | -7.12 | -14.24 | 1.93 | -2.85 | 0.1094 | -- | 36.95 | 40.70 | 61.13 | -- | -4.39 | -- |
| Indivior PLC | 489.72m | 69.03m | 1.10bn | 819.00 | 17.53 | 9.22 | 13.54 | 2.25 | 0.0856 | 0.0856 | 0.6131 | 0.1627 | 0.4316 | 1.29 | 3.96 | 597,950.80 | 6.08 | 5.18 | 10.54 | 12.07 | 83.98 | 87.55 | 14.09 | 8.00 | 1.79 | 12.33 | 0.6323 | 0.00 | -17.58 | -8.59 | -210.45 | -- | -33.60 | -- |
Data as of Jul 26 2021. Currency figures normalised to Oxford BioMedica PLC's reporting currency: UK Pound GBX
40.04%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Vulpes Investment Management Pte Ltd.as of 09 Jun 2021 | 9.87m | 11.95% |
| M&G Investment Management Ltd.as of 15 Mar 2021 | 7.13m | 8.64% |
| Liontrust Investments Ltd.as of 02 Jul 2021 | 3.83m | 4.64% |
| Hargreaves Lansdown Asset Management Ltd.as of 15 Mar 2021 | 3.09m | 3.74% |
| Artisan Partners LPas of 15 Mar 2021 | 2.62m | 3.17% |
| Banque Pictet & Cie SAas of 02 Jul 2021 | 1.77m | 2.14% |
| UBS Asset Management Switzerland AGas of 02 Jul 2021 | 1.57m | 1.90% |
| Amati Global Investors Ltd.as of 02 Jul 2021 | 1.09m | 1.33% |
| BlackRock Investment Management (UK) Ltd.as of 02 Jul 2021 | 1.07m | 1.30% |
| Threadneedle Asset Management Ltd.as of 02 Jul 2021 | 1.03m | 1.24% |
More ▼
Data from 31 Mar 2021 - 08 Jul 2021Source: FactSet Research Systems Inc.
